Onchocerciasis: A review of a filarial disease of significant importance for dermatologists and ophthalmologists
Keywords:
Onchocerciasis, onchodermatitis, Onchocerca volvulus, black flyAbstract
Onchocerciasis is a common, chronic, multisystemic disease caused by the nematode Onchocerca volvulus. The disease characteristically includes dermatologic, lymphatic, ophthalmologic, and systemic manifestations. It is transmitted to humans by a bite from the intermediate host, the black fly (Simulium damnosum). It is endemic in Western andCentral Africa and approximately 95% of all infected people live in these regions. Onchocerciasis has been associated with a high incidence of detrimental effects on socioeconomic development and public health in endemic areas. We, here inAsia, hardly see any case of this disease but due to globalization, frequent international traveling and deployment of military troops from Asian countries (as a part of UN forces) in endemic African countries. We should expect such diseases in our region also and should have a high index of suspicion. Here is a review of this troublesome filarial disease with emphasis of its clinical spectrum, so that dermatologists, ophthalmologists and physicians in our region would be able to keep this disease in mind as a differential diagnosis of some unusual case of dermatitis, blindness or arthritis etc. Patients described (figures) in this article are author’s own collection during one year stay inSierra Leone (an endemic country ofWest Africa for the disease).References
Manson P. Filaria Volvuloxus. In Hygiene and Diseases of Warm Climates. (Davidson AH.). Y.J. Pentland, London.p.1016.1893.
O’Neill J. On the presence of filarial in “Craw Craw”. Lancet 1875; 1: 265-6.
Robles R. Enfermidad nueva en Guatemala. Juventad Med 1917; 17: 97-115.
Blacklock DB. The insect transmission of Onchocerca volvulus (Leukart 1893.) The cause of worm nodule in man in Africa. BMJ 1927; 1: 129-33.
Maso MJ, Kapila R, Schwartz RA et al. Cutaneous onchocerciasis. Int J Dermatol 1987; 26: 593-6.
Murdoch ME, Hay RJ, Mackenzie CD et al. A clinical classification and grading system of the cutaneous changes in onchocerciasis. Br J Dermatol 1993; 129: 260-9.
Duke BO. The population dynamics of Onchocerca volvulus in the human host. Trop Med Parasitol 1993; 44: 61-8.
Buttner DW, von Laer G, Mannweiler E, Buttner M. Clinical, parasitological and serological studies on onchocerciasis in the Yemen Arab Republic. Tropenmed Parasitol 1982; 33: 201-12.
Dozie IN, Onwuliri CO, Nwoke BE, Onwuliri VA. Clinical and parasitological aspects of onchocercal skin diseases in Nigeria. Trop Doct 2005; 35: 142-4.
Trpis M. Consequences of vector behavior in epidemiology of onchocerciasis on the firestone rubber plantation in Liberia. Am J Trop Med Hyg 2006; 74: 833-40.
Krueger A. Guide to blackflies of the Simulium damnosum complex in eastern and southern Africa. Med Vet Entomol 2006; 20:60-75.
Levine R and the What Work Working group. Millions Saved, Proven Safe in Global Health, 6 case, Controlling Onchocerciasis in Sub-Saharan Africa. Washington DC: Centre for Global Development; 2004. p. 57-64.
Richards FO, Miri E, Meredith S, et al. Onchocerciasis. Bull World Health Organ 1998; 76 (Suppl 2): 147-9.
Burnham G: Onchocerciasis. Lancet 1998; 351: 1341-6.
Hailu A, Balcha F, Birrie H et al. Prevalence of onchocercal skin disease and infection among workers of coffee plantation farms in Teppi, Southwestern Ethiopia. Ethiop Med J 2002; 40: 259-69.
Brooker S, Clements AC, Bundy DA. Global epidemiology, ecology and control of soil-transmitted helminth infections. Adv Parasitol 2006; 62: 221-61.
Michael E, Bundy DAP, Grenfell BT. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 1996, 112: 409-28.
Murdoch ME, Asuzu MC, Hagan M et al. Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa. Ann Trop Med Parasitol 2002; 96: 283-96.
Kale OO. Onchocerciasis: the burden of disease. Ann Trop Med Parasitol 1998; 92: S101-15.
Stingl P. Onchocerciasis: clinical presentation and host parasite interactions in patients of Southern Sudan. Int J Dermatol 1997; 36: 23-8.
Connor DH, Williams PH, Helwig EB, Winslow DJ. Dermal changes in onchocerciasis. Arch Pathol 1969; 87: 193-200.
Hagan M. Onchocercal dermatitis: clinical impact. Ann Trop Med Parasitol 1998; 92: S85-96.
Lazarov A, Amihai B, Sion-Vardy N. Pruritus and chronic papular dermatitis in an Ethiopian man. Onchocerciasis (chronic papular onchodermatitis). Arch Dermatol 1997; 133: 382-3, 385-6.
Meyers WM, Neafie RC, Connor DH. Onchocerciasis: invasion of deep organs by Onchocerca volvulus. Am J Trop Med Hyg 1977; 26: 650-7.
Vernick W, Turner SE, Burov E, Telang GH. Onchocerciasis presenting with lower extremity, hypopigmented macules. Cutis 2000; 65: 293-7.
Kipp W, Bamhuhiiga J. Onchodermal skin disease in a hyperendemic onchocerciasis focus in western Uganda. Am J Trop Med Hyg 2002; 67: 475-9.
Mahe E, Torchet MF, Chretiennot C et al. Papular filariasis. Arch Pediatr 2001; 8: 604-7.
Richard-Lenoble D, al Qubati Y, Toe L et al. Human onchocerciasis and "sowda" in the Republic of Yemen. Bull Acad Natl Med 2001; 185: 1447-59; discussion 1459-61.
Boatin BA, Toe L, Alley ES et al. Diagnostics in onchocerciasis: future challenges. Ann Trop Med Parasitol 1998; 92: S41-5.
Ayong LS, Tume CB, Wembe FE et al. Development and evaluation of an antigen detection dipstick assay for the diagnosis of human onchocerciasis. Trop Med Int Health 2005; 10: 228-33.
Rodríguez-Pérez MA, Domínguez-Vázquez A, Méndez-Galván J et al. Antibody detection tests for Onchocerca volvulus: comparison of the sensitivity of a cocktail of recombinant antigens used in the indirect enzyme-linked immunosorbent assay with a rapid-format antibody card test. Trans R Soc Trop Med Hyg 2003; 97: 539-41.
Stingl P, Ross M, Gibson DW et al. A diagnostic "patch test" for onchocerciasis using topical diethylcarbamazine. Trans R Soc Trop Med Hyg 1984; 78: 254-8.
Toe L, Adjami AG, Boatin BA, Back C, Alley ES, Dembele N, et al. Topical application of diethylcarbamazine to detect onchocerciasis recrudescence in west Africa. Trans R Soc Trop Med Hyg 2000; 94: 519-25.
Toe L, Boatin BA, Adjami A et al. Onchocerca volvulus infection by O-150 polymerase chain reaction analysis of skin scratches. J Infect Dis 1998; 178: 282-5.
Weil GJ, Steel C, Liftis F et al. A rapid-format antibody card test for diagnosis of onchocerciasis. J Infect Dis 2000; 182: 1796-9.
Baraka OZ, Mahmoud BM, Ali MM et al. Ivermectin treatment in severe asymmetric reactive onchodermatitis (sowda) in Sudan. Trans R Soc Trop Med Hyg 1995; 89: 312-5.
Burnham G. Ivermectin treatment of onchocercal skin lesions: observations from a placebo-controlled, double-blind trial in Malawi. Am J Trop Med Hyg 1995; 52: 270-6.
Awadzi K, Opoku NO, Attah SK et al. The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment. Ann Trop Med Parasitol 1997; 91: 281-96.
Ogbuagu KF, Eneanya CI. A multi-centre study of the effect of Mectizan treatment on onchocercal skin disease: clinical findings. Ann Trop Med Parasitol 1998; 92 (Suppl 1): S139-45.
Pacque M, Elmets C, Dukuly ZD et al. Improvement in severe onchocercal skin disease after a single dose of ivermectin. Am J Med 1991; 90: 590-4.
Mackenzie CD, Geary TG, Gerlach JA. Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients. Filaria J 2003; 2: S1-S5.
Ogbuagu KF, Eneanya CI. A multicentre study of the treatment on onchocercal skin clinical findings effect of Mectizan disease: Ann Trop Med Parasitol 1998; 92: 139-45.
Awadzi K, Edwards G, Duke BO et al. The co-administration of ivermectin and albendazole-safety, pharmacokinetics and efficacy against Onchocerca volvulus. Ann Trop Med Parasitol 2003, 97: 165-78.
Keiser PB, Reynolds SM, Awadzi K et al. Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions. J Infect Dis 2002, 185: 805-11.
Ali MM, Baraka OZ, AbdelRahman SI et al. Immune responses directed against microfilariae correlate with severity of clinical onchodermatitis and treatment history. J Infect Dis 2003; 187: 714-7.
Debrah AY, Mand S, Marfo-Debrekyei Y et al. Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin. Filaria J 2006; 5: 1-9.
Richards F, Hopkins D, Cupp E. Programmatic goals and approaches to onchocerciasis. Lancet 2000; 355: 1663-4.
Evans BD, Gelband H, Vlassoff C. Social and economical factors and the control of lymphatic filariasis a review. Acta Trop 1993, 53: 1-26.
Ottesen EA, Duke BOL, Karam M, Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 1997, 75: 491-503.
Hoerauf A. Control of filarial infections: not the beginning of the end, but more research is needed. Curr Opin Infect Dis 2003, 16: 1-8.
Dadzie Y, Neira M, Hopkins D. Final report of the Conference on the eradicability of onchocerciasis. Filaria J 2003, 2: 2-10.
Abiose A, Homeida M, Liese B et al. Onchocerciasis control strategies. Lancet 2000, 356: 1523-4.
Little MP, Breitling LP, Basáñez MG et al. Association between microfilarial load and excess mortality in onchocerciasis: an epidemiological study. Lancet 2004; 363: 1514-21.
